Print
12 November 2015
PitchBook Blog
4Q 2015 M&A Report takes a look into aggregate M&A activity across North America and Europe, spotlighting a few key industries and analyzing sponsor-backed trends. As it turns out, total M&A value is on track for an all-time record, spurred by massive numbers in the B2C and healthcare sectors.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.